By www.reliablebusinessinsights.com
Global And United States Metabolic Disorder Therapeutics Market Report & Forecast 2024-2031 Story
112
$ 4350
Metabolic Disorder Therapeutics Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Novo Nordisk A/S Sanofi S.A. Boehringer Ingelheim GmbH Eli Lilly and Company Merck KgaA Amgen, Inc. AstraZeneca PLC Actelion Pharmaceuticals Ltd. Shire PLC AbbVie, Inc. Biocon Ltd. BioMarin Pharmaceutical, Inc. Bristol-Myers Squibb Company Cipla, Inc. CymaBay Therapeutics, Inc.